Progress toward establishing an open access molecular screening capability in the Australasian Region

ACS Chemical Biology

Volumn 2, Issue 12, 2007, Pages 764-767

  Camp, David ^a   Avery, Vicky ^a   Street, Ian ^b   Quinn, Ronald J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA AND NEW ZEALAND; DRUG INDUSTRY; DRUG RESEARCH; ENVIRONMENTAL IMPACT; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HIGH THROUGHPUT SCREENING; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PATENT; PRIORITY JOURNAL;

AUSTRALASIA; DRUG EVALUATION, PRECLINICAL;

EID: 38649136965     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb7002384     Document Type: Article

References (16)

1. Hopkins, A. L., and Groom, C. R. (2002) The druggable genome, Nat. Rev. Drug Discovery 1, 727-730.
2. Lazo, J. S., Brady, L. S., and Dingledine, R. (2007) Building a pharmacological lexicon: small molecule discovery in academia, Mol. Pharmacol. 72, 1-7.
3. Austin, C. P., Brady, L. S., Insel, T. R., and Collins, F. S. (2004) NIH molecular libraries initiative, Science 306, 1138-1139.
4. Hergenrother, P. J. (2006) Obtaining and screening compound collections: a user's guide and a call to chemists, Curr. Opin. Chem. Biol. 10, 213-218.
5. Gordon. E. J. (2007) Small-molecule screening: it take a village, ACS Chem. Biol. 2 9-16.
6. Lewis, J. D. (2007) The role of the chemical biology core facility at EMBL: a vision for a European roadmap, ACS Chem. Biol. 2, 21-23.
7. Department of Education, Science and Training (2003) Mapping Australian Science and Innovation, Australian Government.
8. Department of Industry, Tourism and Resources (2002) Pharmaceutical Industry Action Agenda: Local Priority - Global Partner, Australian Government.
9. Simpson, G. (2005) Drug discovery: a case for national coordination, Chem. Aust. 72, 22.
10. Camp, D. (2007) Establishment of an open access compound management facility in Australia to stimulate applied, basic and translational research, Drug Discovery World, Spring61-66.
11. Department of Education, Science and Training (2006). National Collaborative Research Infrastructure Strategy Strategic Roadmap, Australian Government.
12. Dobson, C. M. (2004) Chemical space and biology, Nature 432, 824-828.
13. Stockwell, B. R. (2004) Exploring biology with small organic molecules, Nature 432, 846-854.
14. Lipinski, C., and Hopkins, A. (2004) Navigating chemical space for biology and medicine, Nature 432, 855-861.
15. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (1997) Experimental and computational approaches to estimate solubitity and permeability in drug discovery and development settings, Adv. Drug. Delivery Rev. 23, 3-25.
16. Leeson, P. D., Davis, A. M., and Steele, J. (2004) Drug like properties: guiding principles for chemical design-or chemical prejudice? Drug Discovery Today: Technol. 1, 189-195.